Decade-long bacterial community dynamics in cystic fibrosis airways. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, Vandevanter DR, Murray S, Li JZ, Young VB, Lipuma JJ Proceedings of the National Academy of Sciences of the United States of America, 2012 Apr 10, Volume 109, Issue 15, p.5809-14, (2012)
Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators. Owens P, Pickup MW, Novitskiy SV, Chytil A, Gorska AE, Aakre ME, West J, Moses HL Proceedings of the National Academy of Sciences of the United States of America, 2012 Feb 21, Volume 109, Issue 8, p.2814-9, (2012)
Bone-density testing interval and transition to osteoporosis in older women. Gourlay ML, Fine JP, Preisser JS, May RC, Li C, Lui L-Y, Ransohoff DF, Cauley JA, Ensrud KE The New England journal of medicine, 2012 Jan 19, Volume 366, Issue 3, p.225-33, (2012)
Bacteroides fragilis-stimulated interleukin-10 contains expanding disease. Cohen-Poradosu R, McLoughlin RM, Lee JC, Kasper DL The Journal of infectious diseases, 2011 Aug 1, Volume 204, Issue 3, p.363-71, (2011)
SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. Yang M, Xie W, Mostaghel E, Nakabayashi M, Werner L, Sun T, Pomerantz M, Freedman M, Ross R, Regan M, Sharifi N, Figg WD, Balk S, Brown M, Taplin M-E, et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011 Jun 20, Volume 29, Issue 18, p.2565-73, (2011)
LIN28B promotes colon cancer progression and metastasis. King CE, Cuatrecasas M, Castells A, Sepulveda AR, Lee J-S, Rustgi AK Cancer research, 2011 Jun 15, Volume 71, Issue 12, p.4260-8, (2011)
Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis. Healy BC, Engler D, Gholipour T, Weiner H, Bakshi R, Chitnis T Journal of the neurological sciences, 2011 Apr 15, Volume 303, Issue 1-2, p.109-13, (2011)